Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7.

Dou Y, Li Y, Chen J, Wu S, Xiao X, Xie S, Tang L, Yan M, Wang Y, Lin J, Zhu W, Yan G.

Oncol Lett. 2013 Mar;5(3):1010-1016. Epub 2013 Jan 11.

2.

TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.

Chen J, Dou Y, Zheng X, Leng T, Lu X, Ouyang Y, Sun H, Xing F, Mai J, Gu J, Lu B, Yan G, Lin J, Zhu W.

Tumour Biol. 2016 Nov;37(11):14721-14731. Epub 2016 Sep 14.

PMID:
27629139
3.

Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation.

Jiang J, Li MH, Inoue K, Chu XP, Seeds J, Xiong ZG.

Cancer Res. 2007 Nov 15;67(22):10929-38.

4.

[Transient receptor potential melastatin 7 channel protein in human head and neck carcinoma cells and role in cell proliferation].

Jiang J, Lei WB, Shi JB, Su ZZ, Xiong ZG.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Jun;43(6):451-5. Chinese.

PMID:
18826101
5.

Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels.

Zierler S, Yao G, Zhang Z, Kuo WC, Pƶrzgen P, Penner R, Horgen FD, Fleig A.

J Biol Chem. 2011 Nov 11;286(45):39328-35. doi: 10.1074/jbc.M111.264341. Epub 2011 Sep 16.

6.

Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells.

Callera GE, He Y, Yogi A, Montezano AC, Paravicini T, Yao G, Touyz RM.

J Hypertens. 2009 Jan;27(1):155-66.

PMID:
19145781
7.

Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression.

Dou YL, Lin JP, Liu FE, Wang LY, Shu HH, Jiang N, Xie Y, Duan Q.

Tumour Biol. 2014 Aug;35(8):7499-504. doi: 10.1007/s13277-014-1991-0. Epub 2014 May 2.

PMID:
24789432
8.

Role of transient receptor potential melastatin type 7 channel in gastric cancer.

Kim BJ, Hong C.

Integr Med Res. 2016 Jun;5(2):124-130. doi: 10.1016/j.imr.2016.04.004. Epub 2016 Apr 11. Review.

10.
11.

Regulation of basal autophagy by transient receptor potential melastatin 7 (TRPM7) channel.

Oh HG, Chun YS, Park CS, Kim TW, Park MK, Chung S.

Biochem Biophys Res Commun. 2015 Jul 17-24;463(1-2):7-12. doi: 10.1016/j.bbrc.2015.05.007. Epub 2015 May 15.

PMID:
25983327
12.

Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration.

Rybarczyk P, Gautier M, Hague F, Dhennin-Duthille I, Chatelain D, Kerr-Conte J, Pattou F, Regimbeau JM, Sevestre H, Ouadid-Ahidouch H.

Int J Cancer. 2012 Sep 15;131(6):E851-61. doi: 10.1002/ijc.27487. Epub 2012 Apr 17.

13.

Inhibition of TRPM7 Attenuates Rat Aortic Smooth Muscle Cell Proliferation Induced by Angiotensin II: Role of Genistein.

Yang M, Zhao T, Lin J, Ju T, Zhang L.

J Cardiovasc Pharmacol. 2015 Jul;66(1):16-24. doi: 10.1097/FJC.0000000000000238.

PMID:
26164719
14.

Involvement of TRPM7 in cell growth as a spontaneously activated Ca2+ entry pathway in human retinoblastoma cells.

Hanano T, Hara Y, Shi J, Morita H, Umebayashi C, Mori E, Sumimoto H, Ito Y, Mori Y, Inoue R.

J Pharmacol Sci. 2004 Aug;95(4):403-19. Epub 2004 Jul 24.

15.

TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.

Fang L, Zhan S, Huang C, Cheng X, Lv X, Si H, Li J.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):713-25. doi: 10.1016/j.taap.2013.08.009. Epub 2013 Aug 16.

PMID:
23958495
16.

Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target.

Yee NS.

Pharmaceuticals (Basel). 2017 Apr 5;10(2). pii: E39. doi: 10.3390/ph10020039. Review.

17.

Mg(2+)- and ATP-dependent inhibition of transient receptor potential melastatin 7 by oxidative stress.

Inoue H, Murayama T, Tashiro M, Sakurai T, Konishi M.

Free Radic Biol Med. 2014 Jul;72:257-66. doi: 10.1016/j.freeradbiomed.2014.04.015. Epub 2014 Apr 18.

18.

Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain.

Guilbert A, Gautier M, Dhennin-Duthille I, Rybarczyk P, Sahni J, Sevestre H, Scharenberg AM, Ouadid-Ahidouch H.

Eur J Cancer. 2013 Nov;49(17):3694-707. doi: 10.1016/j.ejca.2013.07.008. Epub 2013 Aug 1.

PMID:
23910495
19.

Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta.

Zhang Z, Wang M, Fan XH, Chen JH, Guan YY, Tang YB.

Circ Res. 2012 Oct 12;111(9):1137-46. doi: 10.1161/CIRCRESAHA.112.273755. Epub 2012 Aug 14. Erratum in: Circ Res. 2012 Dec 7;111(12):e391-2.

20.

Transient receptor potential melastatin 7 channels are involved in ginsenoside Rg3-induced apoptosis in gastric cancer cells.

Kim BJ, Nah SY, Jeon JH, So I, Kim SJ.

Basic Clin Pharmacol Toxicol. 2011 Oct;109(4):233-9. doi: 10.1111/j.1742-7843.2011.00706.x. Epub 2011 May 18.

Supplemental Content

Support Center